These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25546793)

  • 1. Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.
    Gamez J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):134-5. PubMed ID: 25546793
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L; Horváth R; Bárdosi Z; Szobor A
    Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile myasthenia gravis: treatment with immune globulin and thymectomy.
    Herrmann DN; Carney PR; Wald JJ
    Pediatr Neurol; 1998 Jan; 18(1):63-6. PubMed ID: 9492094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary treatment for prepubertal juvenile myasthenia gravis with crisis.
    Hirata Y; Inoue M; Nabatame S; Okumura M; Ozono K
    Pediatr Int; 2016 Aug; 58(8):772-4. PubMed ID: 27324449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy.
    Chu XY; Xue ZQ; Wang RW; Tan QY
    Chin Med J (Engl); 2011 Apr; 124(8):1246-50. PubMed ID: 21543005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis.
    Leuzzi G; Meacci E; Cusumano G; Cesario A; Chiappetta M; Dall'armi V; Evoli A; Costa R; Lococo F; Primieri P; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):e76-88; discussion e88. PubMed ID: 24525106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P; Tranchant C; Clair B; Bolgert F; Eymard B; Stojkovic T; Attarian S; Chevret S;
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia].
    Pérez Nellar J; Domínguez AM; Llorens-Figueroa JA; Ferrá-Betancourt A; Pardo A; Quiala M; Gali Z
    Rev Neurol; 2001 Sep 1-15; 33(5):413-6. PubMed ID: 11727205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of myasthenic crisis after extended thymectomy in patients with generalized myasthenia gravis].
    Liu WB; Men LN; Tang BY; Huang RX
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2737-40. PubMed ID: 17199991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive care in myasthenic and cholinergic crises].
    Popova LM; Piradov MA
    Anesteziol Reanimatol; 1996; (2):13-5. PubMed ID: 8754165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
    Mahalati K; Dawson RB; Collins JO; Mayer RF
    J Clin Apher; 1999; 14(1):1-8. PubMed ID: 10355656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune system, Part 2: Myasthenia gravis.
    Stephens A
    Nurs Times; 1997 Nov 12-18; 93(46):56-9. PubMed ID: 9418490
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis.
    Ando T; Omasa M; Kondo T; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Sonobe M; Date H
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):705-9; discussion 709. PubMed ID: 25618314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission.
    Prokakis C; Koletsis E; Salakou S; Apostolakis E; Baltayiannis N; Chatzimichalis A; Papapetropoulos T; Dougenis D
    Ann Thorac Surg; 2009 Nov; 88(5):1638-45. PubMed ID: 19853124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
    Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
    Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
    Gajdos P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.